Singapore approves Gilead’s remdesivir to treat Covid-19
Singapore's Health Sciences Authority (HSA) has awarded conditional approval for Gilead Sciences Singapore's experimental antiviral...
Coronavirus in Singapore: COVID-19 measures and impact
The Wuhan coronavirus outbreak (COVID-19, earlier 2019-nCov) that originated in China has spread to Singapore...
Arcturus Therapeutics partners with medical school for coronavirus vaccine
Arcturus Therapeutics, a RNA medicines company, and Duke-NUS Medical School have partnered to develop a...
AUM Biosciences to develop Inflection’s cancer therapy
Biotechnology firm AUM Biosciences has entered a global licence agreement for Inflection Biosciences’ series of...
Everest Medicines to commercialise Calliditas’ Nefecon in Greater China and Singapore
Sweden-based Calliditas Therapeutics has announced that Everest Medicines will commercialise its IgA nephropathy (IgAN) drug...
ASLAN Pharmaceuticals acquires rights to atopic dermatitis asset
ASLAN Pharmaceuticals has amended its licensing agreement with CSL to obtain complete worldwide rights to...
AI technology to help design personalised combination therapy
A research team led by the National University of Singapore (NUS) has developed an artificial...
Chugai Pharmaceutical to expand Singaporean research subsidiary
Japan-based Chugai Pharmaceutical has revealed plans to expand its research subsidiary in Singapore, Chugai Pharmabody...
Deals this week: Sanofi, EBOS, Menarini Asia-Pacific Holdings
Sanofi has signed an agreement with Evotec to integrate its infectious disease unit into the...
M&As this week: Strides Pharma Asia, GlaxoSmithKline
Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company...